![](/img/cover-not-exists.png)
SLV310, a molecule combining potent dopamine D2 receptor antagonism with serotonin reuptake inhibition, active in preclinical models for antipsychotic as well as anxiolytic activity
T. Tuinstra, A.H.J. Herremans, J.A.M. Van der Heyden, A.C. McCreary, M.B. Hesselink, C.G. Kruse, S.K. LongVolume:
11
Year:
2001
Language:
english
DOI:
10.1016/s0924-977x(01)80288-1
File:
PDF, 150 KB
english, 2001